AB
AND Biotech utilizes proprietary polynucleotide technology to develop therapeutic solutions aimed at combating antibiotic resistance and enhancing microbiome health. The company’s platform offers a natural alternative to traditional antibiotics, promoting global health and longevity through its one-health approach.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- AND Biotech utilizes proprietary polynucleotide technology to develop therapeutic solutions aimed at combating antibiotic resistance and enhancing microbiome health. The company’s platform offers a natural alternative to traditional antibiotics, promoting global health and longevity through its one-health approach.